Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial
Phase: PHASE2 | Sponsor: Brigham and Women's Hospital | Compound: Psilocybin
- Status
- planned
- Institution
- Brigham and Women's Hospital
- Start date
- 2026-05-01
- End date
- 2030-02-01
- Registry ID
- NCT07296094
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.